J&J’s Janssen Secures Exclusive Global Rights to Develop LCB84 ADC from LegoChem Biosciences
Johnson & Johnson’s (J&J; NYSE: JNJ) pharmaceutical subsidiary, Janssen, has entered into an exclusive global...
LegoChem Biosciences
LaNova Medicines and LegoChem Biosciences Partner to Develop Innovative ADC Product
Shanghai-based cancer therapy developer LaNova Medicines Ltd has entered into a research partnership agreement with...